Because all of these organizations use WADA and USADA banned substances list, and BPC-157 is currently classified as Not FDA approved Classified as experimental Peptide with potential performance/recovery effects It will be interesting to see how this changes if/when it gets changed to Category 1, likely later this year by the FDA
BPC-157 is a synthetic 15-amino-acid peptide (MW 1,419.5 g/mol, CAS 137525-51-0) derived from a gastric-juice protein
Opt for a liposomal liquid or a high-bioavailability format
measured B12 levels in 51 mothers, placentas, and infants post-delivery, and found that the intervillous space in the placenta contained a higher concentration of B12 (796 pmol/l) than the blood of the mothers (590 pmol/l) or their newborns (252 pmol/l)
Metabolic profile displayed differential metabolic features in 3 resistance groups (4+1, 50, and 35x6) compared to control by using cryogenic probe NMR spectroscopy